BASFs, Buyback

BASF's Buyback Wind-Down Meets a Harder Test in Louisiana

Published on 11/17/2026 at 14:31 | Editorial boerse-global.de
BASF finished its share repurchase and commissioned a $1 billion MDI plant in Louisiana, but Jefferies downgraded the stock on margin and overcapacity concerns.
BASFs, Buyback, Wind-Down, Meets, Harder, Test, Louisiana, BASF, MDI, Jefferies Illustration mit AI erstellt.

BASF has finished repurchasing shares under its current programme, but the more consequential question for investors sits several thousand miles away on the Louisiana Gulf Coast. The Ludwigshafen-based chemicals group bought back 591,344 of its own shares last week for a total of EUR 32,155,122.20, a transaction confirmed yesterday. Since the programme began, roughly 8.54 million shares have been retired. The stock slipped 1.2% in the prior session.

Those two data points — a completed buyback and a softer share price — frame the debate now facing shareholders. Returning capital is straightforward; earning an adequate return on the capital already committed to new plant is not.

A billion-dollar bet now has to pay

On 11 November BASF formally commissioned its new MDI production facility at the Geismar integrated site in Louisiana. The investment came to approximately USD 1 billion, and annual MDI capacity at the location rises to around 600,000 tonnes. That figure describes production potential, not the volumes or profits BASF will actually book. The project has moved from the drawing board to the income statement, and the margin it earns will determine whether the outlay was wise.

The timing matters. Capital has just flowed back to shareholders at the same moment the company must prove that its largest recent industrial commitment can hold its own commercially. Judged in isolation, neither the buyback nor the Geismar start-up settles the investment case. More capacity is only valuable if it can be sold into sufficient demand at sustainable prices.

Should investors sell immediately? Or is it worth buying BASF?

Jefferies takes the other side

Priyanka Patel of Jefferies downgraded BASF on 11 November from "Hold" to "Underperform," keeping a price target of 44 euros. Her reasoning cuts directly against the bull case for Geismar: falling margins, persistent overcapacity, higher gas prices and no sign of a demand recovery. She expects operating profit for 2027 to come in 5% below consensus — an analyst projection rather than a reported result.

Should those pressures persist, the enlarged MDI capacity would struggle to generate much economic value. Commissioning would remain an industrial milestone, but not proof of improved profitability. Buybacks would not offset that operational headwind either, making it risky to read the capital return as evidence of a durable earnings upturn.

Seeds and green power round out the pipeline

Two further items sit alongside the Louisiana project, at different stages of delivery. BASF Agricultural Solutions reported progress yesterday in the global rollout of its Nemasphere soybean trait against nematodes, putting peak sales potential at more than EUR 300 million. Launches in the US and Brazil are planned from 2028, and the company says the latest EU import approval completes the authorisations currently required in key export markets.

Separately, BASF has committed to switching its entire suitable European polyisobutene portfolio for external customers to electricity from renewable sources, effective January 2027. That change lies ahead and should not be confused with the Geismar start-up, which is already complete. Nor does the power switch carry any quantifiable margin benefit on its own.

What investors should actually watch

The favourable scenario does not require buybacks to create growth. It requires BASF to make its existing investments work: Geismar running at healthy utilisation, margins steadying, and the 2027 polyisobutene conversion and 2028 soy launches arriving on schedule. Under those conditions, capital returns would sit on a firmer earnings base and the shares would look more attractive.

The bear case is equally concrete. If overcapacity and cost pressure intensify, the drag on operations would outweigh the benefit of any capital returned. The next scheduled implementation step is dated; the decisive test remains profitability.

Ad

BASF Stock: New Analysis - 17 November

Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated BASF analysis...

Disclaimer...
en | DE000BASF111 | BASFS | boerse | 70527157 |